We have studied the efficacy of urea in the treatment of hyponatremia and hydrosaline retention in cirrhotic patients with ascites resistant to diuretics. In 5 patients with hyponatremia and ascites resistant to a major diuretic treatment (200–400 mg spironolactone combined with 40–160 mg furosemide/day for 4 of them), urea intake (30–90 g/day) induced the following changes: the daily weight changed from a gain of 0.01 ± 0.06 kg/day to a loss of 1.03 ± 0.12 kg/day (p < 0.001) (mean ± SEM), serum sodium concentration rose from 128 ± 1.3 to 133 ± 1.4 mmol/l (p < 0.01), sodium output increased from 24 ± 4 to 82.5 ± 11 mmol/day, diuresis increased from 1.05 ± 0.10 to 2.24 ± 0.24 liters/day (p < 0.01). Despite an important weight loss, the creatinine clearance did not change significantly (53.6 ± 4.5 ml/min before and 70.0 ± 8.2 ml/min during urea). In patients responding to classical diuretics, urea as a monotherapy was less effective. From the 6 patients with resistant ascites, only 1 developed prerenal uremia after urea treatment. In order to enhance urea efficacy, it is important to take it together with a long-loop diuretic. Intermittent urea intake seemed to be useful in cirrhotic patients with hyponatremia associated with ascites resistant to diuretics and with low or normal blood urea concentrations.

Keywords:
Urea, Hyponatremia, Osmotic diuresis, Ascites, Cirrhosis
This content is only available via PDF.
© 1986 S. Karger AG, Basel
1986
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.